[Ip-health] Greece to Boost Share of Generics in Drugs Market, Minister Says
claire.cassedy at keionline.org
Fri Mar 14 18:31:42 PDT 2014
Greece to Boost Share of Generics in Drugs Market, Minister Says
By Nikos Chrysoloras and Antonis Galanopoulos Mar 6, 2014 5:01 PM ET
Greece wants to triple the share of generic drugs prescribed by the end of
next year, closing the gap to targets set by international creditors under
the terms of the country's bailout, Health Minister Adonis Georgiades said.
The share of generics in the total volume of prescription drugs sold in
Greece will rise to "at least" 30 percent by the end of 2014, compared with
19.8 percent at the end of last year, closer to a national target for a 60
percent share, Georgiades said in an interview in Athens yesterday. The
minister said he would consider less than 30 percent at the end of 2014 a
"failure" and that 60 percent goal will probably be reached by the end of
The share of copycat drugs sold in Greece is still very low compared to the
European average of more than 70 percent, Georgiades said, adding that the
government will cut the average treatment price gradually every six months,
to allow local manufacturers to adapt to international competition.
Cuts in public spending on drugs is one of the conditions attached to
Greece's bailout, supported by 240 billion euros ($331 billion) in loans
from the euro-area member states and theInternational Monetary Fund. The
market for generic medicine in the country is about 500 million euros a
year a number that will increase to about 750 million euros when Greece
reaches the 60 percent mark, the minister said.
Georgiades said Greece has copycat drugs of "high quality," dismissing
concerns about drugs imported from developing countries and adding that
targeted reductions to regulated prices won't affect quality.
"We are talking about the same drugs used everywhere in Europe," he said.
"I haven't heard of European patients suffering en masse from low-quality
Georgiades said he strongly opposes demands from international creditors to
allow the sale of non-prescription drugs in supermarkets and the
deregulation of pharmacies.
"The point is to land the plane, not crash it," he said. Greece has about
11,500 pharmacies, when 6,000 would be sufficient for its needs, he said.
At the same time, it has more specialized doctors and fewer general
practitioners and nurses compared with other European Union member-states.
"An army full of generals, and few soldiers," the minister said. "We know
that this is not sustainable, but we don't want to take measures that will
lead half of the country's pharmacies into bankruptcy. We should remember
that unemployment in Greece is 28 percent."
Georgiades said there aren't vested interests in the health-care sector
that enjoy government protection.
"In 2009, the size of the drugs market in Greece was 5.6 billion euros, and
pharmacies were operating with a 30 percent profit margin," he said. "Now,
the market has shrunk to 2 billion euros with a 20 percent profit margin.
We don't offer special protection, we're just giving the industry
sufficient time to adapt in the new reality."
More information about the Ip-health